Zinexts
A One-Stop Shop for Streamlining Molecular Diagnostics Workflows

The first step in molecular diagnostics, sample collection and preservation, is crucial in delivering desired clinical and research outcomes.

Prioritizing this, Zinexts provides innovative laboratory instrumentation that maintains the utmost quality and ensures streamlined efficiencies across the sample collection, extraction, and detection.

Specialized in DNA/RNA extraction, Zinexts designs, develops, and manufactures devices and reagents to align with the project development needs of an original equipment manufacturer (OEM) and original design manufacturer (ODM). It offers advanced extraction instruments under its flagship MagPurix series. Further complementing its extraction kits are Zinexts’ unique sample collection tools with preservation and pretreatment buffers that enable optimized collection efficiency.

For providing complete solutions from sample to result, Zinexts’ approach involves understanding the specific needs of OEM or ODM partners and designing solutions that fulfill the partners’ unique requirements. By leveraging its expertise in extraction kit development and automation, Zinexts optimizes the workflow to accommodate proper resources and save time, labor, and space. Furthermore, Zinexts’ focus on customizability enables it to develop tailored platforms for customers seeking cutting-edge approaches for obtaining actionable results.

“Our offerings fit the majority of market-available samples and seamlessly integrate with multiplex qPCR assays, two-step amplification protocols, NGS, and other testing requirements,” says Hartmut Goette, VP of Commercial Operations at Zinexts.

Its core values of ingenuity, integrity, and impact are reflected in Goette’s emphasis on maintaining a company culture and identity of vigilance about ongoing issues in the healthcare and disease reduction verticals. Possessing this mindset, Zinexts works to create disruptive solutions and introduce varied implementation methods that enable quick, cost-effective, and reliable patient diagnostic results.

Zinexts’ capabilities extend beyond IT, incorporating extensive engineering research and development. The firm’s IT team collaborates closely with the engineering team to create and develop advanced solutions that enhance the functionality, efficiency, and user experience of its products.

Meanwhile, Zinexts’ dedicated marketing and sales divisions regularly attend leading conferences and international domain exhibitions to engage with potential clients and present them with optimized solutions. From a product distribution perspective, Zinexts’ exceptional distributor base attends regional and local conferences to better manage its outlets across five continents and expand its global presence. Through these competencies, Zinexts aims to deliver impactful outcomes and better patient care methodologies in the public health and disease reduction domains.

This combination of reliability and a proven ability to boost clinical performance makes Zinexts a sought-after company in the APAC region. A success story portraying its advantages is of a group of clients looking to acquire its solution for criminal casework and forensics applications, which involved human identity testing. In this instance, Zinexts provided a personalized DNA extraction kit that significantly improved their forensics extraction and analysis needs. It is working to acquire ISO certifications to fulfill this clientele’s forensic-grade DNA requirements.

During the pandemic, Zinexts was pivotal as the first company to provide complete testing equipment and reagents for an Australian COVID-19 testing lab.

Our offerings fit the majority of market-available samples and seamlessly integrate with multiplex qPCR assays, two-step amplification protocols, NGS, and other testing requirements

Due to its exceptional customer experiences, many organizations approach Zinexts through referrals. It also has excellent feedback, valuable testimonies, and multiple peer-reviewed publications that display its adaptability to diverse client needs.

Looking ahead, Zinexts aims to be more active on LinkedIn, implement a YouTube channel, and create informative social media pages and newsletters for educating its partners on relevant molecular diagnostics subjects.

By Q4 2023, Zinexts will be the fourth company in the world (and first in APAC) to acquire a forensics ISO certification and assist in resolving more common and critical healthcare issues related to cancer and genetic testing. It also plans to launch its first sample-to-result instrument that evaluate primary samples and address the automation demands of sophisticated molecular diagnostic workflows. These tools will enable users to run the whole process, from extraction and qPCR setup to amplification, detection, and result analysis, in two hours with a button push.

Moving forward, Zinexts will extend its current qPCR analysis solution to become a reliable molecular diagnostics solution provider that competently addresses evolving market, business, and patient needs.